BioKDE

Clinical Trial
Meta-Analysis
Randomized Controlled Trial
Review
Systematic Review

1 year

5 year

10 year

Start Date:

End Date:

2,313,590 results (0.543 seconds)

Modelling cancer in microfluidic human organs-on-chips.
Alexandra Sontheimer-Phelps, Bryan A Hassell, Donald E Ingber.
Nat Rev Cancer. 2019 Jan 17; 19(2):65-81. PMID: 30647431
Highly Cited. Review.

A view on drug resistance in cancer.
Neil Vasan, José Baselga, David M Hyman.
Nature. 2019 Nov 13; 575(7782):299-309. PMID: 31723286 Free PMC article
Highly Cited. Review.

Phosphatidylinositol 3-Kinase, Growth Disorders, and Cancer.
Marcus D Goncalves, Benjamin D Hopkins, Lewis C Cantley.
N Engl J Med. 2018 Nov 22; 379(21):2052-2062. PMID: 30462943
Highly Cited. Review.

Applications of Immunogenomics to Cancer.
X Shirley Liu, Elaine R Mardis.
Cell. 2017 Feb 12; 168(4):600-612. PMID: 28187283 Free PMC article
Highly Cited. Review.

Proteasome inhibitors in cancer therapy.
Elisabet E Manasanch, Robert Z Orlowski.
Nat Rev Clin Oncol. 2017 Jan 24; 14(7):417-433. PMID: 28117417 Free PMC article
Highly Cited. Review.

Controversies around epithelial-mesenchymal plasticity in cancer metastasis.
Elizabeth D Williams, Dingcheng Gao, Andrew Redfern, Erik W Thompson.
Nat Rev Cancer. 2019 Oct 30; 19(12):716-732. PMID: 31666716 Free PMC article
Highly Cited. Review.

An RNA toolbox for cancer immunotherapy.
Fernando Pastor, Pedro Berraondo, +4 authors, Ignacio Melero.
Nat Rev Drug Discov. 2018 Sep 07; 17(10):751-767. PMID: 30190565
Highly Cited. Review.

Dendritic cells in cancer immunology and immunotherapy.
Stefanie K Wculek, Francisco J Cueto, +3 authors, David Sancho.
Nat Rev Immunol. 2019 Aug 29; 20(1):7-24. PMID: 31467405
Highly Cited. Review.

Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Wei Tang, Wenpei Fan, +3 authors, Xiaoyuan Chen.
Chem Soc Rev. 2019 May 16; 48(11):2967-3014. PMID: 31089607
Highly Cited. Review.

Targeting cancer vulnerabilities with high-dose vitamin C.
Bryan Ngo, Justin M Van Riper, Lewis C Cantley, Jihye Yun.
Nat Rev Cancer. 2019 Apr 11; 19(5):271-282. PMID: 30967651 Free PMC article
Highly Cited. Review.

Antibody-drug conjugates for cancer therapy.
Anish Thomas, Beverly A Teicher, Raffit Hassan.
Lancet Oncol. 2016 Jun 15; 17(6):e254-e262. PMID: 27299281 Free PMC article
Highly Cited. Review.

The broken cycle: E2F dysfunction in cancer.
Lindsey N Kent, Gustavo Leone.
Nat Rev Cancer. 2019 May 06; 19(6):326-338. PMID: 31053804
Highly Cited. Review.

Leptomeningeal metastases in non-small-cell lung cancer.
Haiying Cheng, Roman Perez-Soler.
Lancet Oncol. 2018 Jan 06; 19(1):e43-e55. PMID: 29304362
Highly Cited. Review.

Improving immune-vascular crosstalk for cancer immunotherapy.
Yuhui Huang, Betty Y S Kim, +3 authors, Wen Jiang.
Nat Rev Immunol. 2018 Jan 15; 18(3):195-203. PMID: 29332937 Free PMC article
Highly Cited. Review.

Rare ribosomopathies: insights into mechanisms of cancer.
Anna Aspesi, Steven R Ellis.
Nat Rev Cancer. 2019 Jan 24; 19(4):228-238. PMID: 30670820
Highly Cited. Review.

Optimizing the outcomes of pancreatic cancer surgery.
Oliver Strobel, John Neoptolemos, Dirk Jäger, Markus W Büchler.
Nat Rev Clin Oncol. 2018 Oct 21; 16(1):11-26. PMID: 30341417
Highly Cited. Review.

Turning foes to friends: targeting cancer-associated fibroblasts.
Xueman Chen, Erwei Song.
Nat Rev Drug Discov. 2018 Nov 25; 18(2):99-115. PMID: 30470818
Highly Cited. Review.

Phagocytosis checkpoints as new targets for cancer immunotherapy.
Mingye Feng, Wen Jiang, +3 authors, Irving L Weissman.
Nat Rev Cancer. 2019 Aug 28; 19(10):568-586. PMID: 31462760 Free PMC article
Highly Cited. Review.

NTRK fusion-positive cancers and TRK inhibitor therapy.
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon.
Nat Rev Clin Oncol. 2018 Oct 20; 15(12):731-747. PMID: 30333516 Free PMC article
Highly Cited. Review.

A history of exploring cancer in context.
Shelly Maman, Isaac P Witz.
Nat Rev Cancer. 2018 Apr 28; 18(6):359-376. PMID: 29700396
Highly Cited. Review.

Previous

Next